PillSeek

Reviewed by PillSeek Editorial Team · Last updated

Trilipix

Fenofibric acid 135 mg;

About This Medication

This medication is a Yellow;blue Capsule 22 mm, Delayed release capsule with imprint "135". It contains Fenofibric acid 135 mg; of Fenofibric acid[fenofibric acid];. This belongs to the Peroxisome proliferator receptor alpha agonist pharmacologic class. It is manufactured by AbbVie Inc.. For details please contact your physician.

Basic Information

Imprint
135
Color
Yellow;blue
Shape
Capsule
Size
22 mm

Drug Information

Strength
Fenofibric acid 135 mg;
Dosage Form
Delayed release capsule
RxCUI
828377

Pharmaceutical Classification

Related Medications

Other drugs in the same class: Peroxisome Proliferator Receptor alpha Agonist

Ingredients

Active Ingredients
Fenofibric acid[fenofibric acid];
Inactive Ingredients
Methacrylic acid - ethyl acrylate copolymer (1:1) type a;water;silicon dioxide;sodium stearyl fumarate;talc;triethyl citrate;titanium dioxide;fd&c blue no. 2;ferric oxide yellow;hydroxypropyl cellulose (1600000 wamw);povidone, unspecified;gelatin, unspecified;hypromellose, unspecified;

Additional Information

Manufacturer
AbbVie Inc.
Status (Rx/OTC)
Rx
Brand Names
Trilipix

⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.

Yellow;blue Capsule Trilipix Fenofibric acid 135 mg; Pill With Imprint 135 | PillSeek